基蛋生物 - Financials

基蛋生物 — Financial Statements

Annual Quarterly

5 10 All

Income Statement

Balance Sheet

Cash Flow

Line Item	FY 2024Dec 31, 2024	FY 2023Dec 31, 2023	FY 2022Dec 31, 2022	FY 2021Dec 31, 2021	FY 2020Dec 31, 2020
+Revenue	1.2B	1.4B	1.8B	1.4B	1.1B
Revenue Growth %	-14.9%	-24.9%	30.0%	24.8%	--
Total Revenue	1.2B	1.4B	1.8B	1.4B	1.1B
Cost Of Revenue	358.0M	460.0M	636.0M	482.0M	415.0M
+Gross Profit	807.0M	909.0M	1.2B	920.0M	708.0M
Gross Margin %	69.3%	66.4%	65.1%	65.6%	63.0%
Total Operating Cost	946.0M	1.1B	1.3B	994.0M	817.0M
Selling Expenses	276.0M	333.0M	303.0M	234.0M	183.0M
Admin Expenses	95.7M	107.0M	104.0M	90.6M	75.9M
Rd Expenses	181.0M	218.0M	223.0M	163.0M	119.0M
Finance Expenses	-35.3M	-50.4M	-31.7M	-3.2M	-605,300
+Operating Income	258.0M	307.0M	563.0M	453.0M	378.0M
Operating Margin %	22.1%	22.4%	30.9%	32.3%	33.7%
Non Operating Income	2.1M	1.6M	1.6M	630,600	416,400
Non Operating Expenses	6.7M	3.2M	4.9M	1.8M	4.4M
Investment Income	827,100	15.5M	16.1M	27.9M	18.1M
Fair Value Change Income	149,400	10.2M	18.5M	-4.3M	24.4M
Asset Disposal Income	1.6M	668,300	17,200	1.1M	642,300
Asset Impairment Loss	41.8M	19.2M	35.2M	3.0M	-879,500
Other Income	36.4M	31.3M	18.7M	20.5M	28.5M
Income Before Tax	253.0M	305.0M	560.0M	452.0M	374.0M
Income Tax	23.6M	20.9M	56.0M	39.6M	43.7M
+Net Income	230.0M	284.0M	504.0M	412.0M	330.0M
Net Margin %	19.7%	20.7%	27.7%	29.4%	29.4%
Net Income Attributable	224.0M	280.0M	499.0M	399.0M	305.0M
Minority Interest	6.2M	4.3M	5.0M	13.0M	25.6M
Eps Basic	0.44	0.55	0.98	0.79	0.84
Eps Diluted	0.44	0.55	0.98	0.78	0.84

Line Item	FY 2024Dec 31, 2024	FY 2023Dec 31, 2023	FY 2022Dec 31, 2022	FY 2021Dec 31, 2021	FY 2020Dec 31, 2020
Cash And Equivalents	352.0M	484.0M	646.0M	969.0M	802.0M
Trading Financial Assets	649.0M	452.0M	511.0M	613.0M	595.0M
Accounts Receivable	356.0M	445.0M	494.0M	439.0M	457.0M
Notes Receivable	--	600,000	--	--	2.0M
Notes And Accounts Receivable	356.0M	445.0M	494.0M	439.0M	459.0M
Prepayments	11.0M	22.7M	61.5M	30.2M	24.6M
Inventory	194.0M	230.0M	269.0M	252.0M	212.0M
Total Current Assets	1.9B	2.2B	2.4B	2.4B	2.1B
Long Term Equity Investment	129.0M	50.9M	66.6M	65.9M	49.6M
Fixed Assets	--	--	459.0M	367.0M	334.0M
Fixed Assets Total	479.0M	488.0M	459.0M	367.0M	334.0M
Construction In Progress	--	--	86.4M	80.9M	35.6M
Construction In Progress Total	225.0M	206.0M	86.4M	80.9M	35.6M
Intangible Assets	142.0M	114.0M	104.0M	77.2M	63.6M
Long Term Deferred Expenses	6.3M	12.0M	13.5M	15.5M	17.5M
Total Non Current Assets	1.9B	1.6B	1.3B	773.0M	583.0M
Total Assets	3.7B	3.8B	3.7B	3.1B	2.7B
Short Term Borrowings	576.0M	641.0M	552.0M	464.0M	365.0M
Accounts Payable	146.0M	129.0M	121.0M	121.0M	102.0M
Advance Receipts	--	--	--	--	--
Contract Liabilities	34.9M	38.2M	75.4M	94.3M	36.0M
Total Current Liabilities	940.0M	978.0M	958.0M	813.0M	657.0M
Long Term Borrowings	--	--	3.0M	27.8M	20.0M
Total Non Current Liabilities	46.4M	52.5M	56.2M	50.4M	39.3M
Total Liabilities	986.0M	1.0B	1.0B	864.0M	696.0M
Paid In Capital	507.0M	507.0M	507.0M	364.0M	260.0M
Capital Reserve	236.0M	314.0M	318.0M	512.0M	612.0M
Surplus Reserve	246.0M	224.0M	200.0M	157.0M	126.0M
Retained Earnings	1.6B	1.5B	1.5B	1.1B	848.0M
Minority Equity	102.0M	182.0M	182.0M	168.0M	166.0M
Equity Attributable	2.6B	2.6B	2.5B	2.1B	1.8B
Total Equity	2.7B	2.7B	2.7B	2.3B	2.0B

Line Item	FY 2024Dec 31, 2024	FY 2023Dec 31, 2023	FY 2022Dec 31, 2022	FY 2021Dec 31, 2021	FY 2020Dec 31, 2020
Cash From Sales	1.3B	1.6B	2.0B	1.6B	1.1B
Tax Refunds Received	9.7M	8.8M	23.9M	4.7M	826,000
Total Operating Cash Inflow	1.4B	1.7B	2.1B	1.6B	1.1B
Cash Paid For Goods	249.0M	468.0M	751.0M	517.0M	403.0M
Cash Paid To Employees	397.0M	427.0M	352.0M	282.0M	225.0M
Taxes Paid	101.0M	157.0M	147.0M	153.0M	98.4M
Total Operating Cash Outflow	971.0M	1.3B	1.6B	1.2B	923.0M
Operating Cash Flow	423.0M	333.0M	483.0M	432.0M	185.0M
Total Investing Cash Inflow	781.0M	335.0M	484.0M	59.7M	49.7M
Total Investing Cash Outflow	1.1B	692.0M	1.2B	314.0M	288.0M
Investing Cash Flow	-348.0M	-357.0M	-760.0M	-255.0M	-239.0M
Cash From Borrowings	1.1B	1.1B	790.0M	495.0M	634.0M
Dividends And Interest Paid	116.0M	221.0M	143.0M	104.0M	116.0M
Debt Repayments	1.1B	1.1B	700.0M	376.0M	364.0M
Total Financing Cash Inflow	1.1B	1.1B	804.0M	507.0M	682.0M
Total Financing Cash Outflow	1.3B	1.3B	850.0M	536.0M	482.0M
Financing Cash Flow	-214.0M	-146.0M	-45.9M	-28.9M	200.0M
Net Change In Cash	-133.0M	-158.0M	-304.0M	148.0M	141.0M
Ending Cash Balance	350.0M	483.0M	641.0M	945.0M	797.0M
Capex	156.0M	258.0M	217.0M	180.0M	114.0M